Virtual Screening of Traditional Chinese Medicine Natural Product Inhibitors Targeting AQP1 for Bladder Cancer
Cancer Reports · 2026-05 · 9 (5)
DOI: 10.1002/cnr2.70570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 08.05.2026. Verfasst von Di Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urinary Surgery, Qiandongnan Prefecture People's Hospital, Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou Province, …. Hauptthemen laut MEDLINE: Aquaporin 1, Urinary Bladder Neoplasms, Medicine, Chinese Traditional, Biological Products. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Institutional research project of Qiandongnan Prefecture People's Hospital.
Abstract (Originalsprache)
Background
Bladder cancer (BCa) is the most common and representative type of adult urinary tract urothelial cancer, characterized by high incidence and mortality rates. It has become a major disease threatening public health, highlighting the urgent need for the development of comprehensive treatment strategies, including traditional Chinese medicine, immunotherapy, and genetic diagnostics. Aquaporin‐1 (AQP1), a water channel protein, mediates water transport across the cell membrane. Recent studies have shown that aquaporins are involved in the development and progression of malignant tumors. In particular, AQP1 plays a significant role in the pathogenesis of bladder cancer and may serve as a potential target for novel drug development. Natural products, owing to their structural diversity, represent a valuable reservoir of lead compounds for drug discovery. Methods and Results In this study, we employed molecular docking and molecular dynamics simulations to screen a library of 2000 traditional Chinese medicine natural compounds for potential activity against the target protein AQP1. The final analysis identified 17 compounds with high binding affinity for the active site of AQP1, indicating their potential as candidate inhibitors. Among these, compounds 8 (Clematignoside), 10 (Ginsenoside Rb2), and 15 (Tannic acid) demonstrated particularly strong binding affinity and complex stability in molecular dynamics simulations.
Conclusion
These findings provide a valuable foundation for the rational design of AQP1‐targeted pharmacophores and suggest promising candidates for the future development of clinical drugs for the treatment of bladder cancer. The top‐ranked compounds, especially compounds 10 and 15, warrant further experimental investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urinary Surgery, Qiandongnan Prefecture People's Hospital, Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou Province, China.
- Department of Urinary Surgery, People's Hospital of Jinping County, Jinping, Guizhou Province, China.
ORCID-Profile: Di Liu, Qing-Yu Zhang
Förderung
- National Natural Science Foundation of China
- Institutional research project of Qiandongnan Prefecture People's Hospital
Zitieren
APA
Liu, D., & Zhang, Q. Y. (2026). Virtual Screening of Traditional Chinese Medicine Natural Product Inhibitors Targeting AQP1 for Bladder Cancer. Cancer Reports, 9(5). https://doi.org/10.1002/cnr2.70570
Vancouver
Liu D, Zhang QY. Virtual Screening of Traditional Chinese Medicine Natural Product Inhibitors Targeting AQP1 for Bladder Cancer. Cancer Reports. 2026;9(5). doi:10.1002/cnr2.70570
BibTeX
@article{Liu2026,
author = {Liu, Di and Zhang, Qing-Yu},
title = {Virtual Screening of Traditional Chinese Medicine Natural Product Inhibitors Targeting AQP1 for Bladder Cancer},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/cnr2.70570}
}
EUVIMED